Hodgkin lymphoma in temporal association with growth hormone replacement

Endocrine Journal

Volumn 52, Issue 5, 2005, Pages 571-575

  Freedman, Renee J ^a,e   Malkovska, Vera ^b   LeRoith, Derek ^c   Collins, Michael T ^d  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b WASHINGTON CANCER INSTITUTE   (United States)

^c NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^d NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^e NONE   (United States)

Author keywords

Hematology; Hormones; Malignancy; Panhypopituitary

Indexed keywords

ALPHA TOCOPHEROL; BLEOMYCIN; BROMOCRIPTINE; BUDESONIDE; CABERGOLINE; CALCIUM; DAUNORUBICIN; DOXORUBICIN; ESTROGEN; GROWTH HORMONE; MEDROXYPROGESTERONE ACETATE; MULTIVITAMIN; PREDNISONE; SEX HORMONE; STEROID; THYROID HORMONE; VINBLASTINE;

ADULT; ARTICLE; BEAM THERAPY; CANCER SURGERY; CASE REPORT; DISEASE ASSOCIATION; FEMALE; GRANULOMATOSIS; HODGKIN DISEASE; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS ADENOMA; HYPOPHYSIS TUMOR; HYPOPITUITARISM; MYOSITIS; TOXICITY;

ADENOMA; ADULT; FEMALE; HODGKIN DISEASE; HUMAN GROWTH HORMONE; HUMANS; MIDDLE AGED; PITUITARY NEOPLASMS;

EID: 27744552295     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.52.571     Document Type: Article

References (25)

1. (2001) Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. J Clin Endocrinol Metab 86: 1868-1870.
2. Zadik Z, Estrov Z, Karov Y, Hahn T, Barak Y (1993) The effect of growth hormone and IGF-I on clonogenic growth of hematopoietic cells in leukemic patients during active disease and during remission - a preliminary report. J Pediatr Endocrinol 6: 79-83.
3. Estrov Z, Meir R, Barak Y, Zaizov R, Zadik Z (1991) Human growth hormone and insulin-like growth factor-1 enhance the proliferation of human leukemic blasts. J Clin Oncol 9: 394-399.
4. Lee PD, Rosenfeld RG, Hintz RL, Smith SD (1986) Characterization of insulin, insulin-like growth factors I and II, and growth hormone receptors on human leukemic lymphoblasts. J Clin Endocrinol Metab 62: 28-35.
5. Weigent DA, Blalock JE (1989) Expression of growth hormone by lymphocytes. Int Rev Immunol 4: 193-211.
6. Murphy WJ, Durum SK, Anver M, Frazier M, Longo DL (1992) Recombinant human growth hormone promotes human lymphocyte engraftment in immunodeficient mice and results in an increased incidence of human Epstein Barr virus-induced B-cell lymphoma. Brain Behav Immun 6: 355-364.
7. Endo M, Kaneko Y, Shikano T, Minami H, Chino J (1988) Possible association of human growth hormone treatment with an occurrence of acute myeloblastic leukemia with an inversion of chromosome 3 in a child of pituitary dwarfism. Med Pediatr Oncol 16: 45-47.
8. Fradkin JE, Mills JL, Schonberger LB, Wysowski DK, Thomson R, Durako SJ, Robison LL (1993) Risk of leukemia after treatment with pituitary growth hormone. Jama 270: 2829-2832.
9. Magnavita N, Sica S, Di Mario A, Leone G (1996) Concurrent epiphyseal fracture and leukemia in a patient treated with growth hormone. Am J Hematol 51: 95-96.
10. Watanabe STY, Komiyama A, Fujimoto J (1988) Leukaemia in patients treated with growth hormone. Lancet 1: 1159-1160.
11. Nishi Y, Tanaka T, Takano K, Fujieda K, Igarashi Y, Hanew K, Hirano T, Yokoya S, Tachibana K, Saito T, Watanabe S (1999) Recent status in the occurrence of leukemia in growth hormone-treated patients in Japan. GH Treatment Study Committee of the Foundation for Growth Science, Japan. J Clin Endocrinol Metab 84: 1961-1965.
12. Forbes GM, Cohen AK (1992) Primary cerebral lymphoma: an association with craniopharyngioma or cadaveric growth hormone therapy? Med J Aust 157: 27-28.
13. Magnavita N, Teofili L, Leone G (1996) Hodgkin's lymphoma in a cyclist treated with growth hormone. Am J Hematol 52: 65-66.
14. Monson JP (2000) Growth hormone (GH) replacement therapy: cancer in adults treated with GH. Growth Horm IGF Res 10 (Suppl A): S50-S51.
15. Swerdlow AJ, Higgins CD, Adlard P, Preece MA (2002) Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 360: 273-277.
16. Jenkins PJ (2000) Acromegaly and colon cancer. Growth Horm IGF Res 10 (Suppl A): S35-S36.
17. Jenkins PJ, Besser GM, Fairclough PD (1999) Colorectal neoplasia in acromegaly. Gut 44: 585-587.
18. Jenkins PJ, Besser M (2001) Clinical perspective: acromegaly and cancer: a problem. J Clin Endocrinol Metab 86: 2935-2941.
19. Jenkins PJ, Fairclough PD, Richards T, Lowe DG, Monson J, Grossman A, Wass JA, Besser M (1997) Acromegaly, colonic polyps and carcinoma. Clin Endocrinol (Oxf) 47: 17-22.
20. Intebi AD, Deutsch SI, Benedetti D, Diez RA (1995) Acromegaly and large cell lymphoma. Acta Haematol 94: 214-215.
21. Pavelic K, Pekic B, Gabrilovac J, Bratic-Mikes V, Boranic M (1981) Hormonal changes in patients with haematological malignancies. Biomedicine 35: 181-184.
22. Wallymahmed ME, Foy P, Shaw D, Hutcheon R, Edwards RH, MacFarlane IA (1997) Quality of life, body composition and muscle strength in adult growth hormone deficiency: the influence of growth hormone replacement therapy for up to 3 years. Clin Endocrinol (Oxf) 47: 439-446.
23. Verhelst J, Abs R, Vandeweghe M, Mockel J, Legros JJ, Copinschi G, Mahler C, Velkeniers B, Vanhaelst L, Van Aelst A, De Rijdt D, Stevenaert A, Beckers A (1997) Two years of replacement therapy in adults with growth hormone deficiency. Clin Endocrinol (Oxf) 47: 485-494.
24. Verhelst J, Abs R (2002) Long-term growth hormone replacement therapy in hypopituitary adults. Drugs 62: 2399-2412.
25. Cuneo RC, Judd S, Wallace JD, Perry-Keene D, Burger H, Lim-Tio S, Strauss B, Stockigt J, Topliss D, Alford F, Hew L, Bode H, Conway A, Handelsman D, Dunn S, Boyages S, Cheung NW, Hurley D (1998) The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults. J Clin Endocrinol Metab 83: 107-116.